• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Research Report on China's Antithrombotic Drug Market, 2013-2017 Product Image

Research Report on China's Antithrombotic Drug Market, 2013-2017

  • Published: December 2012
  • Region: China
  • 40 Pages
  • China Research & Intelligence

Thrombosis refers to the formation of local blood clots. Among it, artery thrombosis can cause myocardial infarction, stroke, acute coronary syndrome, peripheral arterial diseases, etc.; venous thrombosis can cause pulmonary embolism. Arteriovenous thrombosis is the primary reason for incidence and death of cardiovascular diseases, which is also one of the important causes for death of cancer patients.

Nowadays, cardiac-cerebral thrombotic diseases (stroke and myocardial infarction) are severely threatening the life and health of the elderly worldwide. Cardiac-cerebral thrombotic diseases are called as the No.1 killer of the life and health of human beings currently. Cardiac-cerebral thrombotic diseases are characterized by high incidence rate, mortality rate and disability rate as well as suddenness. Since the reform and opening up, because of the continuous improvement in people's living standards as well as the rise in aging trend, the incidence rate of cardiac-cerebral thrombotic diseases continuously rises in China. According to statistics, the proportion of people dying from cardiac-cerebral thrombotic diseases already exceeds 70% in the dead aged above 60 in China's large READ MORE >

1 Overview on Antithrombotic Drugs
1.1 Overview on Thrombosis
1.2 Overview on Global Antithrombotic Drugs
1.2.1 Classification of Antithrombotic Drugs
1.2.2 Anticoagulants
1.2.3 Anti-platelet Aggregation Drugs
1.2.4 Thrombolytic Drugs
1.2.5 Overview on Antithrombotic Drug Market

2 Analysis on China's Antithrombotic Drug Market, 2007-2012
2.1 Market Size of Hospital-use Antithrombotic Drugs
2.2 Market Share of Hospital-use Various Antithrombotic Drugs
2.3 Market Share of Hospital-use Antithrombotic Drugs
2.4 Market Growth Rates of Various Hospital-use Antithrombotic Drugs

3 Analysis on Major Varieties of Antithrombotic Drugs in China's Market
3.1 Heparin Drugs
3.2 Lumbrokinase
3.3 Urokinase
3.4 Sodium Ozagrel and Clopidogrel
3.4.1 Sodium Ozagrel
3.4.2 Clopidogrel
3.5 Rivaroxaban
3.6 Cilostazol
3.7 Alteplase
3.8 Propyl Gallate

4 Prices of China's Major Antithrombotic Drugs for Reference, 2012

5 Prediction on Development of Antithrombotic Drugs
5.1 Prediction on Market Size
5.2 Technology Trend

Selected Charts

Chart Market Size of Global Platelet Aggregation Inhibitors, 2007-2011
Chart Antithrombotic Drugs in the Top 50 Bestselling Drugs Globally, 2011
Chart Market Size of China's Antithrombotic Drugs in Hospitals, 2007-2012
Chart Market Shares of Major Varieties of China's Antithrombotic Drugs in Hospitals, 2007-2011
Chart Top 20 Antithrombotic Drug Manufacturers in China's Hospital Market, 2007-2011
Chart Market Share of China's Low Molecular Weight Heparin Sodium Enterprises in Hospital Drugs, 2010-2011
Chart Specifications and Reference Prices of Major Antithrombotic Drugs in China's Market, 2012
Chart Market Share of China's Alteplase Enterprises in Hospital Drugs, 2010-2011
Chart Prediction on Market Size of China's Antithrombotic Drugs in Hospitals, 2013-2017

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos